Journals Library

An error occurred retrieving publication content to display, please try again.

Page not found (404)

Sorry - the page you requested could not be found.

Please choose a page from the navigation or try a website search above to find the information you need.

5-star GRIP-rated slip-resistant footwear reduced the incidence of slips in the workplace among NHS health-care workers compared with usual footwear.

{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Sarah Cockayne 1,*, Caroline Fairhurst 1, Michael Zand 2, Gillian Frost 3, Mark Liddle 3, Rachel Cunningham-Burley 1, Catherine Hewitt 1, Heather Iles-Smith 4, Lorraine Green 5, Emily Bain 2, Misbah Mogradia 2, David J Torgerson 1

1 York Trials Unit, Department of Health Sciences, University of York, York, UK
2 Health and Safety Executive, Bootle, UK
3 Health and Safety Executive, Buxton, UK
4 Leeds Teaching Hospitals NHS Trust, Leeds, UK
5 National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK
* Corresponding author Email: sarah.cockayne@york.ac.uk

Declared competing interests of authors: Catherine Hewitt declares membership of the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Commissioning Committee (2015–20) and previous membership of the HTA Assessment Commissioning Sub-Board (Expression of Interest) (2016–17). Michael Zand, Gillian Frost, Mark Liddle, Emily Bain and Misbah Mogradia declare that the Health and Safety Executive run the GRIP rating scheme, which was used to identify the footwear and manufacturer used in the trial, and that Shoes for Crews (Europe) Ltd paid the Health and Safety Executive for testing of footwear under the GRIP rating scheme. David J Torgerson declares that he is Director of York Trials Unit, which receives clinical trials unit funding from NIHR, has previously been a member of various boards [a member of the NHS HTA Commissioning Board (from 2007 to 2010), a member of the NIHR Programme Grants for Applied Research Board (from 2007 to 2011) and a member of the MRC methodology research panel (from 2011 to 2013)] and was a member of the Clinical Trials Unit Standing Advisory Committee (2010–14).

Funding: {{metadata.Funding}}

{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}

https://doi.org/{{metadata.DOI}}

Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})

Crossmark status check

Report Content

The full text of this issue is available as a PDF document from the Toolkit section on this page.

The full text of this issue is available as a PDF document from the Toolkit section on this page.

If you would like to receive a notification when this project publishes in the NIHR Journals Library, please submit your email address below.

Responses to this report

No responses have been published.

 

If you would like to submit a response to this publication, please do so using the form below:

Comments submitted to the NIHR Journals Library are electronic letters to the editor. They enable our readers to debate issues raised in research reports published in the Journals Library. We aim to post within 14 working days all responses that contribute substantially to the topic investigated, as determined by the Editors.  Non-relevant comments will be deleted.

Your name and affiliations will be published with your comment.

Once published, you will not have the right to remove or edit your response. The Editors may add, remove, or edit comments at their absolute discretion.

By submitting your response, you are stating that you agree to the terms & conditions

An error has occurred in processing the XML document